Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm.

Sangle NA, Schmidt RL, Patel JL, Medeiros LJ, Agarwal AM, Perkins SL, Salama ME.

Mod Pathol. 2014 Aug;27(8):1137-43. doi: 10.1038/modpathol.2013.238. Epub 2014 Jan 3.

2.

Immunophenotypic analysis of myeloperoxidase-negative leukemia cutis and blastic plasmacytoid dendritic cell neoplasm.

Cronin DM, George TI, Reichard KK, Sundram UN.

Am J Clin Pathol. 2012 Mar;137(3):367-76. doi: 10.1309/AJCP9IS9KFSVWKGH.

PMID:
22338048
3.

Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients.

Julia F, Dalle S, Duru G, Balme B, Vergier B, Ortonne N, Vignon-Pennamen MD, Costes-Martineau V, Lamant L, Dalac S, Delattre C, Déchelotte P, Courville P, Carlotti A, De Muret A, Fraitag S, Levy A, Mitchell A, Petrella T.

Am J Surg Pathol. 2014 May;38(5):673-80. doi: 10.1097/PAS.0000000000000156.

PMID:
24441662
4.

Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm.

Hwang K, Park CJ, Jang S, Chi HS, Huh JR, Lee JH, Suh C, Lee KH.

Histopathology. 2013 Apr;62(5):764-70. doi: 10.1111/his.12079. Epub 2013 Mar 7.

PMID:
23470050
5.

Use of classic and novel immunohistochemical markers in the diagnosis of cutaneous myeloid sarcoma.

Amador-Ortiz C, Hurley MY, Ghahramani GK, Frisch S, Klco JM, Lind AC, Nguyen TT, Hassan A, Kreisel FH, Frater JL.

J Cutan Pathol. 2011 Dec;38(12):945-53. doi: 10.1111/j.1600-0560.2011.01809.x.

PMID:
22050091
6.

TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.

Petrella T, Meijer CJ, Dalac S, Willemze R, Maynadié M, Machet L, Casasnovas O, Vergier B, Teitell MA.

Am J Clin Pathol. 2004 Aug;122(2):307-13.

PMID:
15323148
7.

Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm.

Johnson RC, Kim J, Natkunam Y, Sundram U, Freud AG, Gammon B, Cascio MJ.

Am J Surg Pathol. 2016 Apr;40(4):502-9. doi: 10.1097/PAS.0000000000000595.

PMID:
26796502
8.

An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.

Patel JL, Shetty S, Salama ME.

Am J Dermatopathol. 2011 May;33(3):e31-6. doi: 10.1097/DAD.0b013e3181de9ce0.

PMID:
20861710
9.

Clinicopathological analysis of 46 cases with CD4+ and/or CD56+ immature hematolymphoid malignancy: reappraisal of blastic plasmacytoid dendritic cell and -related neoplasms.

Suzuki Y, Kato S, Kohno K, Satou A, Eladl AE, Asano N, Kono M, Kato Y, Taniwaki M, Akiyama M, Nakamura S.

Histopathology. 2017 Aug 10. doi: 10.1111/his.13340. [Epub ahead of print]

PMID:
28795410
10.

[Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face].

Ahogo KC, Wantz M, Cliquennois M, Gosset P, Lebas D, Modiano P.

Ann Dermatol Venereol. 2014 Jan;141(1):43-7. doi: 10.1016/j.annder.2013.10.042. Epub 2013 Nov 28. French.

PMID:
24461094
11.

Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients.

Cota C, Vale E, Viana I, Requena L, Ferrara G, Anemona L, Metze D, Fink-Puches R, Wiesner T, Cerroni L.

Am J Surg Pathol. 2010 Jan;34(1):75-87. doi: 10.1097/PAS.0b013e3181c5e26b.

PMID:
19956058
12.

TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow.

Alayed K, Patel KP, Konoplev S, Singh RR, Routbort MJ, Reddy N, Pemmaraju N, Zhang L, Shaikh AA, Aladily TN, Jain N, Luthra R, Medeiros LJ, Khoury JD.

Am J Hematol. 2013 Dec;88(12):1055-61. doi: 10.1002/ajh.23567. Epub 2013 Sep 30.

13.

Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases.

Vitte F, Fabiani B, Bénet C, Dalac S, Balme B, Delattre C, Vergier B, Beylot-Barry M, Vignon-Pennamen D, Ortonne N, Algros MP, Carlotti A, Samaleire D, Frouin E, Levy A, Laroche L, Theate I, Monnien F, Mugneret F, Petrella T.

Am J Surg Pathol. 2012 Sep;36(9):1302-16.

PMID:
22895265
14.

[Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study].

Sang W, Wang CF, Cheng YF, Liu X, Li XX, Gulinar A, Li JZ, Zhang W.

Zhonghua Bing Li Xue Za Zhi. 2012 May;41(5):326-30. doi: 10.3760/cma.j.issn.0529-5807.2012.05.009. Review. Chinese.

PMID:
22883672
15.

Sustained complete remission of a limited-stage blastic plasmacytoid dendritic cell neoplasm followed by a simultaneous combination of low-dose DeVIC therapy and radiation therapy: a case report and review of the literature.

Sugimoto KJ, Shimada A, Yamaguchi N, Imai H, Wakabayashi M, Sekiguchi Y, Izumi H, Ota Y, Komatsu N, Noguchi M.

Int J Clin Exp Pathol. 2013 Oct 15;6(11):2603-8. eCollection 2013. Review.

16.

Blastic plasmacytoid dendritic cell neoplasm presenting as leukemia without cutaneous involvement in a 25 years male patient: Unusual presentation of a rare entity.

Qayoom S, Durga G, George S, Rahman K.

Indian J Pathol Microbiol. 2015 Jul-Sep;58(3):377-80. doi: 10.4103/0377-4929.162912.

17.

Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases.

Bénet C, Gomez A, Aguilar C, Delattre C, Vergier B, Beylot-Barry M, Fraitag S, Carlotti A, Dechelotte P, Hospital V, d'Incan M, Costes V, Dereure O, Ortonne N, Bagot M, Laroche L, Blom A, Dalac S, Petrella T.

Am J Clin Pathol. 2011 Feb;135(2):278-90. doi: 10.1309/AJCPFMNYCVPDEND0.

PMID:
21228369
18.
19.

Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group.

Tsagarakis NJ, Kentrou NA, Papadimitriou KA, Pagoni M, Kokkini G, Papadaki H, Pappa V, Marinakis T, Anagnostopoulos NI, Vadikolia C, Anagnostopoulos A, Angelopoulou MK, Terpos E, Poziopoulos C, Anargyrou K, Rontogianni D, Papadaki T, Psarra A, Kontopidou FN, Skoumi D, Papadhimitriou SI, Paterakis G; Hellenic Dendritic Cell Leukemia Study Group.

Leuk Res. 2010 Apr;34(4):438-46. doi: 10.1016/j.leukres.2009.09.006. Epub 2009 Sep 29.

PMID:
19793612
20.

Neoplasms derived from plasmacytoid dendritic cells.

Facchetti F, Cigognetti M, Fisogni S, Rossi G, Lonardi S, Vermi W.

Mod Pathol. 2016 Feb;29(2):98-111. doi: 10.1038/modpathol.2015.145. Epub 2016 Jan 8. Review.

Supplemental Content

Support Center